These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36727938)
1. Repressing IRS1/2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K/AKT/mTOR pathway and inducing autophagy. Li CX; Men CD; Yang WH; Chen R; Zhu JH; Cheng ZP Kaohsiung J Med Sci; 2023 Apr; 39(4):377-389. PubMed ID: 36727938 [TBL] [Abstract][Full Text] [Related]
2. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Rodrigues Alves APN; Fernandes JC; Fenerich BA; Coelho-Silva JL; Scheucher PS; Simões BP; Rego EM; Ridley AJ; Machado-Neto JA; Traina F Cancer Lett; 2019 Aug; 456():59-68. PubMed ID: 31042587 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Zhou J; Jiang YY; Chen H; Wu YC; Zhang L Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522 [TBL] [Abstract][Full Text] [Related]
4. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway. Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
6. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway. Zhu H; Diao S; Lim V; Hu L; Hu J Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187 [TBL] [Abstract][Full Text] [Related]
7. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop. Zhang Q; Zhou X; Wan M; Zeng X; Luo J; Xu Y; Ji L; Zhang JA; Fan P; Zhong J; Wu J Cell Death Dis; 2021 Mar; 12(3):275. PubMed ID: 33723215 [TBL] [Abstract][Full Text] [Related]
8. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells. Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269 [TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells. Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902 [TBL] [Abstract][Full Text] [Related]
11. The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer. Ibuki N; Ghaffari M; Reuveni H; Pandey M; Fazli L; Azuma H; Gleave ME; Levitzki A; Cox ME Mol Cancer Ther; 2014 Dec; 13(12):2827-39. PubMed ID: 25267499 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related]
13. Dual PI3K/mTOR inhibitor PKI-402 suppresses the growth of ovarian cancer cells by degradation of Mcl-1 through autophagy. Hu X; Xia M; Wang J; Yu H; Chai J; Zhang Z; Sun Y; Su J; Sun L Biomed Pharmacother; 2020 Sep; 129():110397. PubMed ID: 32585451 [TBL] [Abstract][Full Text] [Related]
14. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway. Chen S; Yao L Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839 [TBL] [Abstract][Full Text] [Related]
15. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. Wei Z; Xia K; Zheng D; Gong C; Guo W Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274 [TBL] [Abstract][Full Text] [Related]
16. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells. Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150 [TBL] [Abstract][Full Text] [Related]
18. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289 [TBL] [Abstract][Full Text] [Related]
19. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Ma X; Ren H; Zhang Y; Wang B; Ma H Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241 [TBL] [Abstract][Full Text] [Related]
20. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction. Dai J; Sun Y; Chen D; Zhang Y; Yan L; Li X; Wang J Eur J Pharmacol; 2019 Dec; 864():172724. PubMed ID: 31600493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]